General - Press Releases

Date	Title	Company
13-Nov-2023	2 Day Medical Device Design Control Course: Gain Comprehensive Knowledge, Develop Robust Processes, and Implement Competitive Design control Tools - ResearchAndMarkets.com	Businesswire
13-Nov-2023	Essential Preparation and Management Tools for Successful FDA Inspections: What Regulators Expect and How to Prepare (2 Day Online Training Course) - ResearchAndMarkets.com	Businesswire
13-Nov-2023	Environmental Test Chamber Global Markets Report 2023: A Potential $1.107 Billion Opportunity by 2027 with Focus on Customized Chambers, Temperature and Humidity Chambers, & Thermal Shock Chambers - ResearchAndMarkets.com	Businesswire
13-Nov-2023	MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital	Businesswire
13-Nov-2023	Artificial Organs Global Market Report 2023: A Potential $17.7 Billion Opportunity by 2027 - Benefits of Artificial Organs Over Traditional Transplants Drive Market Expansion - ResearchAndMarkets.com	Businesswire
13-Nov-2023	InGeneron Reports Positive Long-Term Results for its Cell Therapy in Partial-Thickness Rotator Cuff Tears	Businesswire
13-Nov-2023	Samsung Launches New Ultrasound System ‘V6’ Where Performance Meets Efficiency	Businesswire
13-Nov-2023	Expanding the Reach of Care for Cancer and Other Disease States: BAMF Health and GE HealthCare collaborate to enable sustainable and scalable solutions for growth in Theranostics	Businesswire
13-Nov-2023	Q2 Announces New Executive Appointments	Businesswire
13-Nov-2023	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of E2open Parent Holdings, Inc. (ETWO) on Behalf of Investors	Businesswire
13-Nov-2023	MedinCell Applauds Teva and Royalty Pharma Collaboration to Further Accelerate Olanzapine LAI Program (Codename: mdc-TJK or TEV-‘749)	Businesswire
13-Nov-2023	MedinCell salue la collaboration entre Teva et Royalty Pharma visant à accélérer le développement du programme olanzapine LAI (nom de code : mdc-TJK ou TEV-‘749)	Businesswire
13-Nov-2023	Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology	Businesswire
13-Nov-2023	Model N Management to Present at the RBC Capital Markets Global Technology, Internet, Media, Telecommunications Conference	Businesswire
13-Nov-2023	Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology	Businesswire
13-Nov-2023	Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3	Businesswire
13-Nov-2023	Thermo Fisher Scientific Opens Customer Experience Center for Battery Manufacturing in Seoul	Businesswire
13-Nov-2023	Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next‑Generation Lithium Therapeutic Drug Candidate AL001	Businesswire
13-Nov-2023	Vir Biotechnology to Present New Data from Its Ongoing Phase 2 Chronic Hepatitis Delta and B Trials Today at AASLD’s The Liver Meeting® 2023	Businesswire
13-Nov-2023	Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program	Businesswire